|
LU75958A1
(enExample)
|
1976-10-08 |
1978-05-16 |
|
|
|
CH636632A5
(de)
|
1976-10-08 |
1983-06-15 |
Ciba Geigy Ag |
Neues verfahren zur herstellung von schwermetallkomplexen.
|
|
GB2025416A
(en)
|
1978-07-14 |
1980-01-23 |
Pfizer Ltd |
Mercaptopyridazinethione antifungal agents
|
|
GB8421427D0
(en)
*
|
1984-08-23 |
1984-09-26 |
Smith Kline French Lab |
Chemical compounds
|
|
EG18314A
(en)
|
1985-09-26 |
1993-02-28 |
Squibb & Sons Inc |
Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
|
|
US4743685A
(en)
|
1985-09-26 |
1988-05-10 |
E. R. Squibb & Sons, Inc. |
2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines
|
|
DK170088A
(da)
|
1987-04-10 |
1988-10-11 |
Hoffmann La Roche |
Acylderivater
|
|
WO1989000423A1
(en)
|
1987-07-09 |
1989-01-26 |
Pfizer Inc. |
2-amino-5-hydroxy-4-pyrimidones
|
|
JPH01202875A
(ja)
|
1988-02-09 |
1989-08-15 |
Fujitsu Ltd |
超伝導材料構造の製造方法
|
|
US5244890A
(en)
|
1988-06-06 |
1993-09-14 |
Fujisawa Pharmaceutical Co., Ltd. |
Cephem compounds
|
|
CA2020654A1
(en)
|
1989-07-07 |
1991-01-08 |
Yohko Akiyama |
Stabilized fgf composition and production thereof
|
|
EP0489515B1
(en)
|
1990-11-22 |
1995-09-20 |
Cerestar Holding Bv |
Process for the production of chocolate
|
|
EP0544166A3
(en)
|
1991-11-26 |
1993-11-03 |
Hoffmann La Roche |
Cephalosporinderivatives
|
|
GB9219313D0
(en)
|
1992-09-11 |
1992-10-28 |
Kodak Ltd |
Method of forming a photographic colour image
|
|
EP0724573A1
(en)
|
1993-10-20 |
1996-08-07 |
PHARMACIA & UPJOHN COMPANY |
Pyrimidinones as antiarthritic and anti-inflammatories
|
|
JP3708962B2
(ja)
|
1994-08-24 |
2005-10-19 |
アストラゼネカ・アクチエボラーグ |
治療に有用なスピロ−アザ二環式化合物
|
|
JPH092534A
(ja)
|
1995-06-16 |
1997-01-07 |
Terada Seisakusho:Kk |
茶貯蔵容器
|
|
JPH0925234A
(ja)
|
1995-07-12 |
1997-01-28 |
Wakunaga Pharmaceut Co Ltd |
脳疾患改善剤
|
|
SE9504661D0
(sv)
|
1995-12-22 |
1995-12-22 |
Astra Pharma Inc |
New compounds
|
|
SE9600683D0
(sv)
|
1996-02-23 |
1996-02-23 |
Astra Ab |
Azabicyclic esters of carbamic acids useful in therapy
|
|
AR013184A1
(es)
|
1997-07-18 |
2000-12-13 |
Astrazeneca Ab |
Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
|
|
SE9702799D0
(sv)
|
1997-07-25 |
1997-07-25 |
Astra Ab |
New compounds
|
|
EP1007515A1
(en)
|
1997-08-22 |
2000-06-14 |
Abbott Laboratories |
Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
|
|
US6525053B1
(en)
|
1997-08-22 |
2003-02-25 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
US6440965B1
(en)
|
1997-10-15 |
2002-08-27 |
Krenitsky Pharmaceuticals, Inc. |
Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
|
|
EP1084704B1
(en)
|
1998-06-10 |
2006-03-29 |
Meiji Seika Kaisha Ltd. |
Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia
|
|
PL198503B1
(pl)
|
1998-10-27 |
2008-06-30 |
Abbott Lab |
Związki pirydazynonowe, kompozycje farmaceutyczne je zawierające oraz ich zastosowanie
|
|
SE9900100D0
(sv)
|
1999-01-15 |
1999-01-15 |
Astra Ab |
New compounds
|
|
SE9903760D0
(sv)
|
1999-10-18 |
1999-10-18 |
Astra Ab |
New compounds
|
|
SE9904176D0
(sv)
|
1999-11-18 |
1999-11-18 |
Astra Ab |
New use
|
|
SE0000540D0
(sv)
|
2000-02-18 |
2000-02-18 |
Astrazeneca Ab |
New compounds
|
|
JP2002028187A
(ja)
|
2000-07-14 |
2002-01-29 |
Toto Ltd |
車いす
|
|
SE0002729D0
(sv)
|
2000-07-20 |
2000-07-20 |
Astrazeneca Ab |
Novel compound form
|
|
WO2002020500A2
(en)
|
2000-09-01 |
2002-03-14 |
Icos Corporation |
Materials and methods to potentiate cancer treatment
|
|
CN101486683B
(zh)
*
|
2000-09-18 |
2011-12-21 |
卫材R&D管理有限公司 |
哒嗪酮和三嗪酮化合物及其作为药物制剂的用途
|
|
DE60139506D1
(de)
|
2000-12-28 |
2009-09-17 |
Shionogi & Co |
2-pyridonderivate mit affinität für den cannabinoid-typ-2-rezeptor
|
|
NZ539828A
(en)
|
2001-05-18 |
2007-01-26 |
Astrazeneca Ab |
4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
|
|
WO2002096912A1
(en)
|
2001-06-01 |
2002-12-05 |
Astrazeneca Ab |
Novel ligand for nicotinic acetylcholine receptors useful in therapy
|
|
AU2002339696A1
(en)
|
2001-12-03 |
2003-06-17 |
Genset S.A. |
Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors
|
|
PT1466912E
(pt)
|
2002-01-18 |
2013-06-28 |
Astellas Pharma Inc |
Derivado de 2-aciloaminotiazol ou seu sal
|
|
BR0309342A
(pt)
|
2002-04-18 |
2005-02-15 |
Astrazeneca Ab |
Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
|
|
JP4523775B2
(ja)
|
2002-04-18 |
2010-08-11 |
アストラゼネカ・アクチエボラーグ |
複素環化合物
|
|
BR0309343A
(pt)
|
2002-04-18 |
2005-02-15 |
Astrazeneca Ab |
Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
|
|
AU2003245669A1
(en)
|
2002-06-21 |
2004-01-06 |
Cellular Genomics, Inc. |
Certain aromatic monocycles as kinase modulators
|
|
SE0202430D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New Compounds
|
|
SE0202465D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New compounds
|
|
SE0202598D0
(sv)
|
2002-09-02 |
2002-09-02 |
Astrazeneca Ab |
Alpha-7 Nicotinic receptor agonists and statins in combination
|
|
MXPA05011387A
(es)
|
2003-04-23 |
2005-12-01 |
Pharmacia & Upjohn Co Llc |
Pirimidinonas y pirimidinotionas sustituidas.
|
|
US7517994B2
(en)
|
2003-11-19 |
2009-04-14 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
|
KR101190912B1
(ko)
|
2003-11-19 |
2012-10-12 |
어레이 바이오파마 인크. |
Ｍｅｋ의 헤테로시클릭 억제제 및 그의 사용 방법
|
|
MY141255A
(en)
|
2003-12-11 |
2010-03-31 |
Memory Pharm Corp |
Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
|
|
NZ548212A
(en)
*
|
2003-12-29 |
2010-07-30 |
Sepracor Inc |
Pyrrole and pyrazole DAAO inhibitors
|
|
ES2332184T3
(es)
|
2004-03-22 |
2010-01-28 |
ELI LILLY & COMPANY |
Derivados de piridilo y su uso como antagonistas del receptor mglu5.
|
|
US20070049611A1
(en)
|
2005-06-10 |
2007-03-01 |
Talamas Francisco X |
Phosphodiesterase 4 inhibitors
|
|
TWI375669B
(en)
|
2006-03-17 |
2012-11-01 |
Sumitomo Chemical Co |
Pyridazinone compound and use thereof
|
|
US7579370B2
(en)
|
2006-06-30 |
2009-08-25 |
Sepracor Inc. |
Fused heterocycles
|
|
KR20090024823A
(ko)
*
|
2006-06-30 |
2009-03-09 |
세프라코 아이엔시. |
Ｄ-아미노산 옥시다제의 융합된 헤테로사이클 억제제
|
|
US20090099248A1
(en)
|
2007-01-18 |
2009-04-16 |
Sepracor Inc. |
Inhibitors of d-amino acid oxidase
|
|
AR064962A1
(es)
|
2007-01-22 |
2009-05-06 |
Syngenta Participations Ag |
Derivados de piridazina utiles como fungicidas
|
|
JP5147866B2
(ja)
|
2007-03-15 |
2013-02-20 |
メルク・シャープ・アンド・ドーム・コーポレーション |
グルカン合成酵素阻害剤として有用であるピリダジノン誘導体
|
|
WO2008116301A1
(en)
|
2007-03-28 |
2008-10-02 |
Apotex Technologies Inc. |
Fluorinated derivatives of deferiprone
|
|
WO2008156607A1
(en)
|
2007-06-12 |
2008-12-24 |
Neurogen Corporation |
Substituted pyrimidinones
|
|
JP2009002534A
(ja)
|
2007-06-19 |
2009-01-08 |
Denso Corp |
熱交換器
|
|
EP2328586A2
(en)
|
2008-05-20 |
2011-06-08 |
Cephalon, Inc. |
Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
|
|
WO2010017418A1
(en)
|
2008-08-07 |
2010-02-11 |
Sepracor Inc. |
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
|
|
WO2010058314A1
(en)
*
|
2008-11-18 |
2010-05-27 |
Pfizer Inc. |
Hydroxyquinolin-2(1h)-ones and derivatives thereof
|
|
BRPI1008498B8
(pt)
|
2009-02-05 |
2021-05-25 |
Takeda Pharmaceuticals Co |
compostos de piridazinona úteis como inibidores da fosfodiesterase 10a, composição farmacêutica, e, uso de um composto
|
|
US20130065857A1
(en)
|
2009-10-12 |
2013-03-14 |
Baylor College Of Medicine |
Novel dxr inhibitors for antimicrobial therapy
|
|
CA2789475C
(en)
|
2010-03-04 |
2018-05-29 |
Merck Sharp & Dohme Corp. |
Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
|
|
US9309199B2
(en)
|
2010-03-04 |
2016-04-12 |
Merck Sharp & Dohme Corp. |
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
|
|
JP5995728B2
(ja)
|
2010-03-04 |
2016-09-21 |
メルク・シャープ・エンド・ドーム・コーポレイション |
カテコールｏ−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用
|
|
US20120046232A1
(en)
|
2010-06-22 |
2012-02-23 |
Medical University Of South Carolina |
Compositions and methods for reducing relapse of addictive behavior
|
|
JP2014518267A
(ja)
|
2011-06-27 |
2014-07-28 |
杏林製薬株式会社 |
細菌感染症の治療のための架橋二環式化合物
|
|
GB201111704D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Novel compounds
|
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
|
JO3115B1
(ar)
|
2011-08-22 |
2017-09-20 |
Takeda Pharmaceuticals Co |
مركبات بيريدازينون واستخدامها كمثبطات daao
|
|
JP2013051513A
(ja)
|
2011-08-30 |
2013-03-14 |
Minebea Co Ltd |
ダンパー及びそれを用いたスピーカ
|
|
AP2014007637A0
(en)
|
2011-11-15 |
2014-05-31 |
Takeda Pharmaceutical |
Dihydroxy aromatic heterocyclic compound
|
|
US8868710B2
(en)
|
2011-11-18 |
2014-10-21 |
Amazon Technologies, Inc. |
Virtual network interface objects
|
|
GB201222711D0
(en)
|
2012-12-17 |
2013-01-30 |
Takeda Pharmaceutical |
Novel compounds
|
|
JP6364420B2
(ja)
|
2013-02-21 |
2018-07-25 |
武田薬品工業株式会社 |
ピリダジノン化合物の製造方法
|
|
GB201403944D0
(en)
|
2014-03-06 |
2014-04-23 |
Takeda Pharmaceutical |
New use
|
|
JP5897196B1
(ja)
|
2015-10-05 |
2016-03-30 |
大同化成工業株式会社 |
糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法
|
|
EP3354283B1
(en)
|
2017-06-20 |
2019-08-07 |
Alfred E. Tiefenbacher (GmbH & Co. KG) |
Pharmaceutical capsule composition comprising silodosin
|
|
US10336724B2
(en)
|
2017-10-18 |
2019-07-02 |
Syneurx International (Taiwan) Corp. |
D-amino acid oxidase inhibitors and therapeutic uses thereof
|
|
TWI873185B
(zh)
|
2019-09-16 |
2025-02-21 |
日商武田藥品工業股份有限公司 |
唑稠合之嗒-3(2h)-酮衍生物
|
|
EP4301367A1
(en)
|
2021-03-01 |
2024-01-10 |
Takeda Pharmaceutical Company Limited |
Use of luvadaxistat for the treatment of cognitive impairment
|